Importance Of Diligent Clinical Trials Marketing And Patient Recruitment

By Author: William Johanna
Total Articles: 9
Comment this article

Before a new drug is introduced or a new treatment regimen is approved, thorough clinical trials must be carried out to test the effectiveness and unearth any side-effects of the drug or treatment procedure. The onus to carry out these clinical trials is on the inventor, in this case a drug company, a medical equipment manufacturer, or even researchers from medical schools. On the other hand there are regulatory bodies such as the FDA whose mandate is to monitor how well nascent medical technologies are standing up to rigorous testing and to give a seal of approval once the trials have revealed positive results.

Clinical trials are not easy undertakings by any means. Perhaps the one thing that accounts for most of the bother in medical trials is patient recruitment and retention. It is estimated that up to one half of the time taken to complete a clinical trial is spent on patient recruitment. Successful clinical trials marketing is critical to the success of any clinical trial. This marketing of course goes hand in hand with using effective clinical trial recruitment strategies to enlist patients for the trials.

What ...
... happens if a company fails to conduct effective clinical trials marketing or uses ineffective clinical trial recruitment strategies? For sure, the company is going to incur significant financial losses and this is for two main reasons. First of all, patient recruitment takes time and costs money. If you are therefore having trouble signing up the right number of participants and retaining them for the duration of the trial, you are bound to overspend on your recruitment budget. Secondly, you will lose money as you delay the launch your product. A delay in launching a product is a direct result of a clinical trial running behind schedule. A drug company loses millions of dollars in potential income for each day it falls behind schedule in addition to the risk of a competitor beating it to the market with a similar product.

Ineffective recruitment strategies for medical trials can also bring a researcher into a collision course with regulators. When it comes to medicines and clinical technology the safety of consumers is paramount and regulators cannot approve anything until they are fully confident of its safety. If a company thus uses suspect recruitment strategies the outcome of its trials will be overshadowed by questions concerning recruitment of participants and this is sufficient reason for regulators to reject the company's findings. The company will be forced to repeat the entire process which will no doubt increase the costs of developing the drug.

Efficient clinical trials marketing is important because it'll inform the public about clinical trials in the offing. Without adequate medical trials marketing eligible patients will never know that they are needed for such an exercise. Again, marketing medical trials is expensive and amounts to little if it's not skillfully done. Most researchers in the medical field have very little technical experience in clinical trial recruitment strategies and marketing clinical trials. To avoid all the pain that can ensue if recruitment is not properly done, researchers are increasingly relying on patient recruitment specialists who have all the technical know-how required for effective patient recruitment.

For more information about clinical trials marketing please visit http://www.ClinicalListAmerica.com